High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis

Cancer

Volumn 120, Issue 17, 2014, Pages 2673-2683

  Zhang, Dong Hong ^a   Chen, Jiong Yu ^b   Hong, Chao Qun ^b   Yi, De Qing ^c   Wang, Fei ^a   Cui, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

DNA methylation; esophageal squamous cell carcinoma; human papillomavirus; prognosis; telomere length

Indexed keywords

PROTEIN E6; PROTEIN E7; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 2;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 21Q; CHROMOSOME 7Q; CHROMOSOME 9Q; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA METHYLATION; E2 GENE; E6 GENE; E7 GENE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HIGH RISK HUMAN PAPILLOMAVIRUS INFECTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TELOMERE ELONGATION; VIRUS GENE; VIRUS LOAD;

DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN PAPILLOMAVIRUS; PROGNOSIS; TELOMERE LENGTH;

CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DOSAGE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 84906789713     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28797     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 517-526.
3. Wang X, Tian X, Liu F, et al. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer. 2010; 10: 19.
4. Shen ZY, Hu SP, Lu LC, et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol. 2002; 68: 412-416.
5. Zhang D, Zhang Q, Zhou L, et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer. 2010; 10: 650.
6. Zhang DH, Zhang QY, Hong CQ, Chen JY, Shen ZY, Zhu Y,. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study. Oncol Rep. 2011; 25: 1731-1738.
7. Zhang QY, Zhang DH, Shen ZY, Xu LY, Li EM, Au WW,. Infection and integration of human papillomavirus in esophageal carcinoma. Int J Hyg Environ Health. 2011; 214: 156-161.
8. Qi Z, Xu X, Zhang B, et al. Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells. Biochem Cell Biol. 2010; 88: 697-704.
9. Vogel G, Pennisi E,. Physiology Nobel. U.S. Researchers recognized for work on telomeres. Science. 2009; 326: 212-213.
10. Artandi SE, DePinho RA,. Telomeres and telomerase in cancer. Carcinogenesis. 2010; 31: 9-18.
11. Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R,. HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A. 2009; 106: 18780-18785.
12. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2649-2655.
13. Hsu CP, Lee LW, Shai SE, Chen CY,. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol. 2005; 11: 6941-6947.
14. Shen ZY, Xu LY, Li EM, et al. The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus. Oncol Rep. 2004; 11: 647-654.
15. Shen ZY, Xu LY, Li C, et al. A comparative study of telomerase activity and malignant phenotype in multistage carcinogenesis of esophageal epithelial cells induced by human papillomavirus. Int J Mol Med. 2001; 8: 633-639.
16. de Lange T,. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005; 19: 2100-2110.
17. Jiang J, Zhao LJ, Zhao C, et al. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells. Gynecol Oncol. 2012; 124: 534-541.
18. Dong W, Wang L, Chen X, Sun P, Wu Y,. Upregulation and CpG island hypomethylation of the TRF2 gene in human gastric cancer. Dig Dis Sci. 2010; 55: 997-1003.
19. Gonzalo S, Jaco I, Fraga MF, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol. 2006; 8: 416-424.
20. Steinert S, Shay JW, Wright WE,. Modification of subtelomeric DNA. Mol Cell Biol. 2004; 24: 4571-4580.
21. Oh BK, Um TH, Choi GH, Park YN,. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis. Int J Cancer. 2011; 128: 857-868.
22. Zhu YH, Yang F, Zhang SS, Zeng TT, Xie X, Guan XY,. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2013; 6: 2497-2505.
23. Zhang D, Chen Y, Xie X, et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. J Mol Cell Cardiol. 2012; 53: 487-496.
24. Zhang D, Xie X, Chen Y, Hammock BD, Kong W, Zhu Y,. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ Res. 2012; 110: 808-817.
25. Lee ME, Rha SY, Jeung HC, Chung HC, Oh BK,. Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Lett. 2009; 281: 82-91.
26. Zhang D, Ai D, Tanaka H, Hammock BD, Zhu Y,. DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. Biochim Biophys Acta. 2010; 1799: 659-667.
27. Cawthon RM,. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30: e47.
28. Rampazzo E, Bertorelle R, Serra L, et al. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer. 2010; 102: 1300-1305.
29. Blasco MA,. Carcinogenesis Young Investigator Award. Telomere epigenetics: a higher-order control of telomere length in mammalian cells. Carcinogenesis. 2004; 25: 1083-1087.
30. Abbott A,. Chromosome protection scoops Nobel. Nature. 2009; 461: 706-707.
31. Greenberg RA, O'Hagan RC, Deng H, et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 1999; 18: 1219-1226.
32. Zhang H, Jin Y, Chen X, et al. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. Cancer Lett. 2007; 245: 184-194.
33. Ohali A, Avigad S, Ash S, et al. Telomere length is a prognostic factor in neuroblastoma. Cancer. 2006; 107: 1391-1399.
34. Oh BK, Kim H, Park YN, et al. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest. 2008; 88: 144-152.
35. Catarino R, Araujo A, Coelho A, et al. Prognostic significance of telomerase polymorphism in non-small cell lung cancer. Clin Cancer Res. 2010; 16: 3706-3712.
36. Ulaner GA, Hoffman AR, Otero J, et al. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer. 2004; 41: 155-162.